Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I drug interactions study of omecamtiv mecarbil in volunteers.

Trial Profile

A phase I drug interactions study of omecamtiv mecarbil in volunteers.

Phase of Trial: Phase I

Latest Information Update: 07 Apr 2009

At a glance

  • Drugs Omecamtiv mecarbil (Primary) ; Diltiazem; Ketoconazole
  • Indications Angina pectoris; Cardiomyopathies; Heart failure
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 13 Jun 2008 Additional results in phenotype groups are expected to be reported in the second half of 2008, according to a Cytokinetics media release.
    • 13 Jun 2008 Interim results data were reported in a Cytokinetics media release.
    • 29 Apr 2008 Cytokinetics has reported that interim results are expected in the second half of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top